Gene · 54915
Papers3,036
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,036
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The N6-methyladenosine Modified EphA10 Promotes Prostate Cancer Progression by Activating the ERK/AKT Pathway. | Biochem Genet | 2026 | 41296142 | PubTator, text mining | PubMed |
| A Biomimetic MOF-Based "Dual-Stage Cumulative Activation" Autophagic Degradation System to Counter Tumor Recurrence Following Incomplete Radiofrequency Ablation of Hepatocellular Carcinoma. | Adv Mater | 2026 | 41292375 | PubTator, text mining | PubMed |
| EZH2 crosstalk with RNA methylation promotes prostate cancer progression through modulation of m6A autoregulation pathway. | J Clin Invest | 2026 | 41252201 | PubTator, text mining | PubMed |
| Noncoding RNAs orchestrating the central dogma. | J Biol Chem | 2026 | 41242393 | PubTator, text mining | PubMed |
| YTHDF1 mediates KLF2/VSIG4 axis to regulate Kupffer cell polarization to alleviate sepsis-induced liver injury. | Genes Immun | 2026 | 41198930 | PubTator, text mining | PubMed |
| Systematic profiling of single-, double- and triple-halogen substitution effects on the mononucleotide binding of N6-methyladenosine to human RNA m6A reader YTHDF1. | Nucleosides Nucleotides Nucleic Acids | 2026 | 41092283 | PubTator, text mining | PubMed |
| Integrative epitranscriptomic and transcriptomic characterization in human colorectal cancer. | J Adv Res | 2026 | 40987397 | PubTator, text mining | PubMed |
| Expression and clinical value of key m6A RNA modification regulators in tuberculosis. | Front Immunol | 2025 | 41613118 | PubTator, text mining | PubMed |
| Epstein-Barr Virus Promotes Gastric Cancer Progression by Modulating m6A-Dependent YTHDF1-TSC22D1 Axis. | Microorganisms | 2025 | 41472023 | PubTator, text mining | PubMed |
| PXDN regulated by WTAP/YTHDF1-mediated m6A modification activates PI3K/AKT signaling pathway through extracellular matrix remodeling to promote progression in nasopharyngeal carcinoma. | J Exp Clin Cancer Res | 2025 | 41413560 | PubTator, text mining | PubMed |
| Decoding m6A readers: roles of YTHDF proteins in leukemogenesis and cancer immunity. | Front Immunol | 2025 | 41403953 | PubTator, text mining | PubMed |
| Activation of the RSAD2-YTHDF1 axis in smooth muscle causes inflammatory bowel disease via intercellular mitochondrial transfer. | Nat Commun | 2025 | 41392079 | PubTator, text mining | PubMed |
| EF24 targets METTL3 to reprogram m6A methylation and induce ferroptosis: an epitranscriptomic mechanism with therapeutical potential for glioma. | Cell Commun Signal | 2025 | 41388311 | PubTator, text mining | PubMed |
| Helicobacter pylori infection aggravates hepatic steatosis by lactylation-driven WTAP-mediated m6A modification. | Gut Microbes | 2025 | 41384837 | PubTator, text mining | PubMed |
| Prognostic potential of N6-methyladenosine methylation-associated genes in lung adenocarcinoma. | Transl Cancer Res | 2025 | 41378023 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A) of LINC01315 promotes hepatocellular carcinoma progression by activating β-Catentin/WNT pathway. | Sci Rep | 2025 | 41372390 | PubTator, text mining | PubMed |
| One RNA-binding protein, many decisions: integrating the transcript life cycle into neuronal regulation. | Front Mol Neurosci | 2025 | 41311672 | PubTator, text mining | PubMed |
| m6A regulators-based gene expression pattern is associated with immune microenvironment characteristics in hepatocellular carcinoma. | Sci Rep | 2025 | 41310383 | PubTator, text mining | PubMed |
| The Role of mRNA Alternative Processing in Mammalian Neurodevelopment. | Int J Mol Sci | 2025 | 41303558 | PubTator, text mining | PubMed |
| RBM15 mediates m6A methylation modification of FOSB mRNA to promote dysfunction of trophoblast cells-a potential link to preeclampsia. | Hereditas | 2025 | 41272900 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54915/papers?page=6